CRMD Butterfly Strategy
CRMD (CorMedix Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
CRMD (CorMedix Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $588.3M, a trailing P/E of 3.63, a beta of 1.46 versus the broader market, a 52-week range of 6.13-17.43, average daily share volume of 1.3M, a public-listing history dating back to 2010, approximately 64 full-time employees. These structural characteristics shape how CRMD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.46 indicates CRMD has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 3.63 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.
What is a butterfly on CRMD?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current CRMD snapshot
As of May 15, 2026, spot at $7.55, ATM IV 50.60%, IV rank 4.91%, expected move 14.51%. The butterfly on CRMD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this butterfly structure on CRMD specifically: CRMD IV at 50.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a CRMD butterfly, with a market-implied 1-standard-deviation move of approximately 14.51% (roughly $1.10 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CRMD expiries trade a higher absolute premium for lower per-day decay. Position sizing on CRMD should anchor to the underlying notional of $7.55 per share and to the trader's directional view on CRMD stock.
CRMD butterfly setup
The CRMD butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CRMD near $7.55, the first option leg uses a $7.17 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CRMD chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CRMD shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $7.17 | N/A |
| Sell 2 | Call | $7.55 | N/A |
| Buy 1 | Call | $7.93 | N/A |
CRMD butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
CRMD butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on CRMD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on CRMD
Butterflies on CRMD are pinning bets - traders use them when they expect CRMD to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
CRMD thesis for this butterfly
The market-implied 1-standard-deviation range for CRMD extends from approximately $6.45 on the downside to $8.65 on the upside. A CRMD long call butterfly is a pinning play: it pays maximum at the middle strike if CRMD settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current CRMD IV rank near 4.91% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CRMD at 50.60%. As a Healthcare name, CRMD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CRMD-specific events.
CRMD butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CRMD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CRMD alongside the broader basket even when CRMD-specific fundamentals are unchanged. Always rebuild the position from current CRMD chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on CRMD?
- A butterfly on CRMD is the butterfly strategy applied to CRMD (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With CRMD stock trading near $7.55, the strikes shown on this page are snapped to the nearest listed CRMD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CRMD butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the CRMD butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 50.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CRMD butterfly?
- The breakeven for the CRMD butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CRMD market-implied 1-standard-deviation expected move is approximately 14.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on CRMD?
- Butterflies on CRMD are pinning bets - traders use them when they expect CRMD to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current CRMD implied volatility affect this butterfly?
- CRMD ATM IV is at 50.60% with IV rank near 4.91%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.